カテゴリー： Market Monitor Global, 世界, 医療/バイオ

関節用注射用ビスコサプリメントの世界市場見通し2023年-2029年

◆英語タイトル：Injectable Viscosupplementation for Joint Market, Global Outlook and Forecast 2023-2029
	◆商品コード：MMG23LY8368 ◆発行会社（リサーチ会社）：Market Monitor Global ◆発行日：2023年7月（※2025年版があります。お問い合わせください。） ◆ページ数：76 ◆レポート形式：英語 / PDF ◆納品方法：Eメール（受注後2-3営業日） ◆調査対象地域：グローバル ◆産業分野：医療機器＆消耗品

◆販売価格オプション（消費税別）

Single User（1名様閲覧用）	USD3,250 ⇒換算￥468,000	見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）	USD4,225 ⇒換算￥608,400	見積依頼/購入/質問フォーム
Enterprise User（閲覧人数制限なし）	USD4,875 ⇒換算￥702,000	見積依頼/購入/質問フォーム

★Market Monitor Globalに受託調査の見積を依頼する

※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

Global Injectable Viscosupplementation for Joint Market 調査レポートは次の情報を含め、グローバルにおけるの関節用注射用ビスコサプリメント市場規模と予測を収録しています。・世界の関節用注射用ビスコサプリメント市場：売上、2018年-2023年、2024年-2029年
・世界の関節用注射用ビスコサプリメント市場：販売量、2018年-2023年、2024年-2029年
・世界のトップ5企業、2022年

世界の関節用注射用ビスコサプリメント市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。アメリカ市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「単回注射」セグメントは今後6年間、000%の年平均成長率で2029年までに000Mドルに成長すると予測されています。

関節用注射用ビスコサプリメントのグローバル主要企業は、Sanofi、 Anika Therapeutics、 Seikagaku、 Zimmer Biomet、 Bioventus、 Ferring、 LG Chem、 Freda、 Haohai Biological、 Shanghai Jingfengなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。

マーケットモニターグローバル社は、関節用注射用ビスコサプリメントのメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。

【セグメント別マーケット分析】

世界の関節用注射用ビスコサプリメント市場：タイプ別、2018年-2023年、2024年-2029年
世界の関節用注射用ビスコサプリメント市場：タイプ別市場シェア、2022年
・単回注射、3回注射、5回注射

世界の関節用注射用ビスコサプリメント市場：用途別、2018年-2023年、2024年-2029年
世界の関節用注射用ビスコサプリメント市場：用途別市場シェア、2022年
・病院、クリニック、その他

世界の関節用注射用ビスコサプリメント市場：地域・国別、2018年-2023年、2024年-2029年
世界の関節用注射用ビスコサプリメント市場：地域別市場シェア、2022年
・北米：アメリカ、カナダ、メキシコ
・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
・アジア：中国、日本、韓国、東南アジア、インド
・南米：ブラジル、アルゼンチン
・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE

【競争分析】

また、当レポートは主要な参入企業の分析を提供します。
・主要企業における関節用注射用ビスコサプリメントのグローバル売上、2018年-2023年
・主要企業における関節用注射用ビスコサプリメントのグローバル売上シェア、2022年
・主要企業における関節用注射用ビスコサプリメントのグローバル販売量、2018年-2023年
・主要企業における関節用注射用ビスコサプリメントのグローバル販売量シェア、2022年

さらに、当レポートは主要企業の情報を提示します。
Sanofi、 Anika Therapeutics、 Seikagaku、 Zimmer Biomet、 Bioventus、 Ferring、 LG Chem、 Freda、 Haohai Biological、 Shanghai Jingfeng

*************************************************************

・調査・分析レポートの概要
関節用注射用ビスコサプリメント市場の定義
市場セグメント
世界の関節用注射用ビスコサプリメント市場概要
当レポートの特徴・ベネフィット
調査手法と情報源

・世界の関節用注射用ビスコサプリメント市場規模
世界の関節用注射用ビスコサプリメント市場規模：2022年 VS 2029年
世界の関節用注射用ビスコサプリメント市場規模と予測 2018年-2029年

・競争状況
グローバルトップ企業
売上ベースでのグローバルトップ企業
企業別グローバルでの関節用注射用ビスコサプリメントの売上
グローバルトップ3およびトップ5企業、2022年売上ベース
グローバル企業の関節用注射用ビスコサプリメント製品タイプ
グローバルにおけるティア1、ティア2、ティア3企業

・タイプ別市場分析
タイプ区分：単回注射、3回注射、5回注射
関節用注射用ビスコサプリメントのタイプ別グローバル売上・予測

・用途別市場分析
用途区分：病院、クリニック、その他
関節用注射用ビスコサプリメントの用途別グローバル売上・予測

・地域別市場分析
地域別関節用注射用ビスコサプリメント市場規模 2022年と2029年
地域別関節用注射用ビスコサプリメント売上・予測
北米市場：アメリカ、カナダ、メキシコ
ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア
アジア市場：中国、日本、韓国、東南アジア、インド
南米市場：ブラジル、アルゼンチン
中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE

・主要企業の情報（企業概要、事業概要、主要製品、売上、ニュースなど）
Sanofi、 Anika Therapeutics、 Seikagaku、 Zimmer Biomet、 Bioventus、 Ferring、 LG Chem、 Freda、 Haohai Biological、 Shanghai Jingfeng
...

Viscosupplementation is a medical procedure during which lubricating fluid is injected into a joint. Also called hyaluronic acid injections or hyaluronan injections, viscosupplementation is most commonly used to treat symptoms of symptoms of knee osteoarthritis.
This report aims to provide a comprehensive presentation of the global market for Injectable Viscosupplementation for Joint, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Injectable Viscosupplementation for Joint. This report contains market size and forecasts of Injectable Viscosupplementation for Joint in global, including the following market information:
Global Injectable Viscosupplementation for Joint Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Injectable Viscosupplementation for Joint Market Sales, 2018-2023, 2024-2029, (Units)
Global top five Injectable Viscosupplementation for Joint companies in 2022 (%)
The global Injectable Viscosupplementation for Joint market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
Single Injection Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Injectable Viscosupplementation for Joint include Sanofi, Anika Therapeutics, Seikagaku, Zimmer Biomet, Bioventus, Ferring, LG Chem, Freda and Haohai Biological, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Injectable Viscosupplementation for Joint manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Injectable Viscosupplementation for Joint Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (Units)
Global Injectable Viscosupplementation for Joint Market Segment Percentages, by Type, 2022 (%)
Single Injection
Three Injection
Five Injection
Global Injectable Viscosupplementation for Joint Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (Units)
Global Injectable Viscosupplementation for Joint Market Segment Percentages, by Application, 2022 (%)
Hospital
Clinic
Other
Global Injectable Viscosupplementation for Joint Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (Units)
Global Injectable Viscosupplementation for Joint Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Injectable Viscosupplementation for Joint revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Injectable Viscosupplementation for Joint revenues share in global market, 2022 (%)
Key companies Injectable Viscosupplementation for Joint sales in global market, 2018-2023 (Estimated), (Units)
Key companies Injectable Viscosupplementation for Joint sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Sanofi
Anika Therapeutics
Seikagaku
Zimmer Biomet
Bioventus
Ferring
LG Chem
Freda
Haohai Biological
Shanghai Jingfeng
Outline of Major Chapters:
Chapter 1: Introduces the definition of Injectable Viscosupplementation for Joint, market overview.
Chapter 2: Global Injectable Viscosupplementation for Joint market size in revenue and volume.
Chapter 3: Detailed analysis of Injectable Viscosupplementation for Joint manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Injectable Viscosupplementation for Joint in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Injectable Viscosupplementation for Joint capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.

❖ レポートの目次 ❖

1 Introduction to Research & Analysis Reports
1.1 Injectable Viscosupplementation for Joint Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Injectable Viscosupplementation for Joint Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Injectable Viscosupplementation for Joint Overall Market Size
2.1 Global Injectable Viscosupplementation for Joint Market Size: 2022 VS 2029
2.2 Global Injectable Viscosupplementation for Joint Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Injectable Viscosupplementation for Joint Sales: 2018-2029
3 Company Landscape
3.1 Top Injectable Viscosupplementation for Joint Players in Global Market
3.2 Top Global Injectable Viscosupplementation for Joint Companies Ranked by Revenue
3.3 Global Injectable Viscosupplementation for Joint Revenue by Companies
3.4 Global Injectable Viscosupplementation for Joint Sales by Companies
3.5 Global Injectable Viscosupplementation for Joint Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Injectable Viscosupplementation for Joint Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Injectable Viscosupplementation for Joint Product Type
3.8 Tier 1, Tier 2 and Tier 3 Injectable Viscosupplementation for Joint Players in Global Market
3.8.1 List of Global Tier 1 Injectable Viscosupplementation for Joint Companies
3.8.2 List of Global Tier 2 and Tier 3 Injectable Viscosupplementation for Joint Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type – Global Injectable Viscosupplementation for Joint Market Size Markets, 2022 & 2029
4.1.2 Single Injection
4.1.3 Three Injection
4.1.4 Five Injection
4.2 By Type – Global Injectable Viscosupplementation for Joint Revenue & Forecasts
4.2.1 By Type – Global Injectable Viscosupplementation for Joint Revenue, 2018-2023
4.2.2 By Type – Global Injectable Viscosupplementation for Joint Revenue, 2024-2029
4.2.3 By Type – Global Injectable Viscosupplementation for Joint Revenue Market Share, 2018-2029
4.3 By Type – Global Injectable Viscosupplementation for Joint Sales & Forecasts
4.3.1 By Type – Global Injectable Viscosupplementation for Joint Sales, 2018-2023
4.3.2 By Type – Global Injectable Viscosupplementation for Joint Sales, 2024-2029
4.3.3 By Type – Global Injectable Viscosupplementation for Joint Sales Market Share, 2018-2029
4.4 By Type – Global Injectable Viscosupplementation for Joint Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Injectable Viscosupplementation for Joint Market Size, 2022 & 2029
5.1.2 Hospital
5.1.3 Clinic
5.1.4 Other
5.2 By Application – Global Injectable Viscosupplementation for Joint Revenue & Forecasts
5.2.1 By Application – Global Injectable Viscosupplementation for Joint Revenue, 2018-2023
5.2.2 By Application – Global Injectable Viscosupplementation for Joint Revenue, 2024-2029
5.2.3 By Application – Global Injectable Viscosupplementation for Joint Revenue Market Share, 2018-2029
5.3 By Application – Global Injectable Viscosupplementation for Joint Sales & Forecasts
5.3.1 By Application – Global Injectable Viscosupplementation for Joint Sales, 2018-2023
5.3.2 By Application – Global Injectable Viscosupplementation for Joint Sales, 2024-2029
5.3.3 By Application – Global Injectable Viscosupplementation for Joint Sales Market Share, 2018-2029
5.4 By Application – Global Injectable Viscosupplementation for Joint Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region – Global Injectable Viscosupplementation for Joint Market Size, 2022 & 2029
6.2 By Region – Global Injectable Viscosupplementation for Joint Revenue & Forecasts
6.2.1 By Region – Global Injectable Viscosupplementation for Joint Revenue, 2018-2023
6.2.2 By Region – Global Injectable Viscosupplementation for Joint Revenue, 2024-2029
6.2.3 By Region – Global Injectable Viscosupplementation for Joint Revenue Market Share, 2018-2029
6.3 By Region – Global Injectable Viscosupplementation for Joint Sales & Forecasts
6.3.1 By Region – Global Injectable Viscosupplementation for Joint Sales, 2018-2023
6.3.2 By Region – Global Injectable Viscosupplementation for Joint Sales, 2024-2029
6.3.3 By Region – Global Injectable Viscosupplementation for Joint Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country – North America Injectable Viscosupplementation for Joint Revenue, 2018-2029
6.4.2 By Country – North America Injectable Viscosupplementation for Joint Sales, 2018-2029
6.4.3 US Injectable Viscosupplementation for Joint Market Size, 2018-2029
6.4.4 Canada Injectable Viscosupplementation for Joint Market Size, 2018-2029
6.4.5 Mexico Injectable Viscosupplementation for Joint Market Size, 2018-2029
6.5 Europe
6.5.1 By Country – Europe Injectable Viscosupplementation for Joint Revenue, 2018-2029
6.5.2 By Country – Europe Injectable Viscosupplementation for Joint Sales, 2018-2029
6.5.3 Germany Injectable Viscosupplementation for Joint Market Size, 2018-2029
6.5.4 France Injectable Viscosupplementation for Joint Market Size, 2018-2029
6.5.5 U.K. Injectable Viscosupplementation for Joint Market Size, 2018-2029
6.5.6 Italy Injectable Viscosupplementation for Joint Market Size, 2018-2029
6.5.7 Russia Injectable Viscosupplementation for Joint Market Size, 2018-2029
6.5.8 Nordic Countries Injectable Viscosupplementation for Joint Market Size, 2018-2029
6.5.9 Benelux Injectable Viscosupplementation for Joint Market Size, 2018-2029
6.6 Asia
6.6.1 By Region – Asia Injectable Viscosupplementation for Joint Revenue, 2018-2029
6.6.2 By Region – Asia Injectable Viscosupplementation for Joint Sales, 2018-2029
6.6.3 China Injectable Viscosupplementation for Joint Market Size, 2018-2029
6.6.4 Japan Injectable Viscosupplementation for Joint Market Size, 2018-2029
6.6.5 South Korea Injectable Viscosupplementation for Joint Market Size, 2018-2029
6.6.6 Southeast Asia Injectable Viscosupplementation for Joint Market Size, 2018-2029
6.6.7 India Injectable Viscosupplementation for Joint Market Size, 2018-2029
6.7 South America
6.7.1 By Country – South America Injectable Viscosupplementation for Joint Revenue, 2018-2029
6.7.2 By Country – South America Injectable Viscosupplementation for Joint Sales, 2018-2029
6.7.3 Brazil Injectable Viscosupplementation for Joint Market Size, 2018-2029
6.7.4 Argentina Injectable Viscosupplementation for Joint Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country – Middle East & Africa Injectable Viscosupplementation for Joint Revenue, 2018-2029
6.8.2 By Country – Middle East & Africa Injectable Viscosupplementation for Joint Sales, 2018-2029
6.8.3 Turkey Injectable Viscosupplementation for Joint Market Size, 2018-2029
6.8.4 Israel Injectable Viscosupplementation for Joint Market Size, 2018-2029
6.8.5 Saudi Arabia Injectable Viscosupplementation for Joint Market Size, 2018-2029
6.8.6 UAE Injectable Viscosupplementation for Joint Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 Sanofi
7.1.1 Sanofi Company Summary
7.1.2 Sanofi Business Overview
7.1.3 Sanofi Injectable Viscosupplementation for Joint Major Product Offerings
7.1.4 Sanofi Injectable Viscosupplementation for Joint Sales and Revenue in Global (2018-2023)
7.1.5 Sanofi Key News & Latest Developments
7.2 Anika Therapeutics
7.2.1 Anika Therapeutics Company Summary
7.2.2 Anika Therapeutics Business Overview
7.2.3 Anika Therapeutics Injectable Viscosupplementation for Joint Major Product Offerings
7.2.4 Anika Therapeutics Injectable Viscosupplementation for Joint Sales and Revenue in Global (2018-2023)
7.2.5 Anika Therapeutics Key News & Latest Developments
7.3 Seikagaku
7.3.1 Seikagaku Company Summary
7.3.2 Seikagaku Business Overview
7.3.3 Seikagaku Injectable Viscosupplementation for Joint Major Product Offerings
7.3.4 Seikagaku Injectable Viscosupplementation for Joint Sales and Revenue in Global (2018-2023)
7.3.5 Seikagaku Key News & Latest Developments
7.4 Zimmer Biomet
7.4.1 Zimmer Biomet Company Summary
7.4.2 Zimmer Biomet Business Overview
7.4.3 Zimmer Biomet Injectable Viscosupplementation for Joint Major Product Offerings
7.4.4 Zimmer Biomet Injectable Viscosupplementation for Joint Sales and Revenue in Global (2018-2023)
7.4.5 Zimmer Biomet Key News & Latest Developments
7.5 Bioventus
7.5.1 Bioventus Company Summary
7.5.2 Bioventus Business Overview
7.5.3 Bioventus Injectable Viscosupplementation for Joint Major Product Offerings
7.5.4 Bioventus Injectable Viscosupplementation for Joint Sales and Revenue in Global (2018-2023)
7.5.5 Bioventus Key News & Latest Developments
7.6 Ferring
7.6.1 Ferring Company Summary
7.6.2 Ferring Business Overview
7.6.3 Ferring Injectable Viscosupplementation for Joint Major Product Offerings
7.6.4 Ferring Injectable Viscosupplementation for Joint Sales and Revenue in Global (2018-2023)
7.6.5 Ferring Key News & Latest Developments
7.7 LG Chem
7.7.1 LG Chem Company Summary
7.7.2 LG Chem Business Overview
7.7.3 LG Chem Injectable Viscosupplementation for Joint Major Product Offerings
7.7.4 LG Chem Injectable Viscosupplementation for Joint Sales and Revenue in Global (2018-2023)
7.7.5 LG Chem Key News & Latest Developments
7.8 Freda
7.8.1 Freda Company Summary
7.8.2 Freda Business Overview
7.8.3 Freda Injectable Viscosupplementation for Joint Major Product Offerings
7.8.4 Freda Injectable Viscosupplementation for Joint Sales and Revenue in Global (2018-2023)
7.8.5 Freda Key News & Latest Developments
7.9 Haohai Biological
7.9.1 Haohai Biological Company Summary
7.9.2 Haohai Biological Business Overview
7.9.3 Haohai Biological Injectable Viscosupplementation for Joint Major Product Offerings
7.9.4 Haohai Biological Injectable Viscosupplementation for Joint Sales and Revenue in Global (2018-2023)
7.9.5 Haohai Biological Key News & Latest Developments
7.10 Shanghai Jingfeng
7.10.1 Shanghai Jingfeng Company Summary
7.10.2 Shanghai Jingfeng Business Overview
7.10.3 Shanghai Jingfeng Injectable Viscosupplementation for Joint Major Product Offerings
7.10.4 Shanghai Jingfeng Injectable Viscosupplementation for Joint Sales and Revenue in Global (2018-2023)
7.10.5 Shanghai Jingfeng Key News & Latest Developments
8 Global Injectable Viscosupplementation for Joint Production Capacity, Analysis
8.1 Global Injectable Viscosupplementation for Joint Production Capacity, 2018-2029
8.2 Injectable Viscosupplementation for Joint Production Capacity of Key Manufacturers in Global Market
8.3 Global Injectable Viscosupplementation for Joint Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Injectable Viscosupplementation for Joint Supply Chain Analysis
10.1 Injectable Viscosupplementation for Joint Industry Value Chain
10.2 Injectable Viscosupplementation for Joint Upstream Market
10.3 Injectable Viscosupplementation for Joint Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Injectable Viscosupplementation for Joint Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer

List of Tables
Table 1. Key Players of Injectable Viscosupplementation for Joint in Global Market
Table 2. Top Injectable Viscosupplementation for Joint Players in Global Market, Ranking by Revenue (2022)
Table 3. Global Injectable Viscosupplementation for Joint Revenue by Companies, (US$, Mn), 2018-2023
Table 4. Global Injectable Viscosupplementation for Joint Revenue Share by Companies, 2018-2023
Table 5. Global Injectable Viscosupplementation for Joint Sales by Companies, (Units), 2018-2023
Table 6. Global Injectable Viscosupplementation for Joint Sales Share by Companies, 2018-2023
Table 7. Key Manufacturers Injectable Viscosupplementation for Joint Price (2018-2023) & (US$/Unit)
Table 8. Global Manufacturers Injectable Viscosupplementation for Joint Product Type
Table 9. List of Global Tier 1 Injectable Viscosupplementation for Joint Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Injectable Viscosupplementation for Joint Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type – Global Injectable Viscosupplementation for Joint Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Global Injectable Viscosupplementation for Joint Revenue (US$, Mn), 2018-2023
Table 13. By Type - Global Injectable Viscosupplementation for Joint Revenue (US$, Mn), 2024-2029
Table 14. By Type - Global Injectable Viscosupplementation for Joint Sales (Units), 2018-2023
Table 15. By Type - Global Injectable Viscosupplementation for Joint Sales (Units), 2024-2029
Table 16. By Application – Global Injectable Viscosupplementation for Joint Revenue, (US$, Mn), 2022 & 2029
Table 17. By Application - Global Injectable Viscosupplementation for Joint Revenue (US$, Mn), 2018-2023
Table 18. By Application - Global Injectable Viscosupplementation for Joint Revenue (US$, Mn), 2024-2029
Table 19. By Application - Global Injectable Viscosupplementation for Joint Sales (Units), 2018-2023
Table 20. By Application - Global Injectable Viscosupplementation for Joint Sales (Units), 2024-2029
Table 21. By Region – Global Injectable Viscosupplementation for Joint Revenue, (US$, Mn), 2022 VS 2029
Table 22. By Region - Global Injectable Viscosupplementation for Joint Revenue (US$, Mn), 2018-2023
Table 23. By Region - Global Injectable Viscosupplementation for Joint Revenue (US$, Mn), 2024-2029
Table 24. By Region - Global Injectable Viscosupplementation for Joint Sales (Units), 2018-2023
Table 25. By Region - Global Injectable Viscosupplementation for Joint Sales (Units), 2024-2029
Table 26. By Country - North America Injectable Viscosupplementation for Joint Revenue, (US$, Mn), 2018-2023
Table 27. By Country - North America Injectable Viscosupplementation for Joint Revenue, (US$, Mn), 2024-2029
Table 28. By Country - North America Injectable Viscosupplementation for Joint Sales, (Units), 2018-2023
Table 29. By Country - North America Injectable Viscosupplementation for Joint Sales, (Units), 2024-2029
Table 30. By Country - Europe Injectable Viscosupplementation for Joint Revenue, (US$, Mn), 2018-2023
Table 31. By Country - Europe Injectable Viscosupplementation for Joint Revenue, (US$, Mn), 2024-2029
Table 32. By Country - Europe Injectable Viscosupplementation for Joint Sales, (Units), 2018-2023
Table 33. By Country - Europe Injectable Viscosupplementation for Joint Sales, (Units), 2024-2029
Table 34. By Region - Asia Injectable Viscosupplementation for Joint Revenue, (US$, Mn), 2018-2023
Table 35. By Region - Asia Injectable Viscosupplementation for Joint Revenue, (US$, Mn), 2024-2029
Table 36. By Region - Asia Injectable Viscosupplementation for Joint Sales, (Units), 2018-2023
Table 37. By Region - Asia Injectable Viscosupplementation for Joint Sales, (Units), 2024-2029
Table 38. By Country - South America Injectable Viscosupplementation for Joint Revenue, (US$, Mn), 2018-2023
Table 39. By Country - South America Injectable Viscosupplementation for Joint Revenue, (US$, Mn), 2024-2029
Table 40. By Country - South America Injectable Viscosupplementation for Joint Sales, (Units), 2018-2023
Table 41. By Country - South America Injectable Viscosupplementation for Joint Sales, (Units), 2024-2029
Table 42. By Country - Middle East & Africa Injectable Viscosupplementation for Joint Revenue, (US$, Mn), 2018-2023
Table 43. By Country - Middle East & Africa Injectable Viscosupplementation for Joint Revenue, (US$, Mn), 2024-2029
Table 44. By Country - Middle East & Africa Injectable Viscosupplementation for Joint Sales, (Units), 2018-2023
Table 45. By Country - Middle East & Africa Injectable Viscosupplementation for Joint Sales, (Units), 2024-2029
Table 46. Sanofi Company Summary
Table 47. Sanofi Injectable Viscosupplementation for Joint Product Offerings
Table 48. Sanofi Injectable Viscosupplementation for Joint Sales (Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 49. Sanofi Key News & Latest Developments
Table 50. Anika Therapeutics Company Summary
Table 51. Anika Therapeutics Injectable Viscosupplementation for Joint Product Offerings
Table 52. Anika Therapeutics Injectable Viscosupplementation for Joint Sales (Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 53. Anika Therapeutics Key News & Latest Developments
Table 54. Seikagaku Company Summary
Table 55. Seikagaku Injectable Viscosupplementation for Joint Product Offerings
Table 56. Seikagaku Injectable Viscosupplementation for Joint Sales (Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 57. Seikagaku Key News & Latest Developments
Table 58. Zimmer Biomet Company Summary
Table 59. Zimmer Biomet Injectable Viscosupplementation for Joint Product Offerings
Table 60. Zimmer Biomet Injectable Viscosupplementation for Joint Sales (Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 61. Zimmer Biomet Key News & Latest Developments
Table 62. Bioventus Company Summary
Table 63. Bioventus Injectable Viscosupplementation for Joint Product Offerings
Table 64. Bioventus Injectable Viscosupplementation for Joint Sales (Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 65. Bioventus Key News & Latest Developments
Table 66. Ferring Company Summary
Table 67. Ferring Injectable Viscosupplementation for Joint Product Offerings
Table 68. Ferring Injectable Viscosupplementation for Joint Sales (Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 69. Ferring Key News & Latest Developments
Table 70. LG Chem Company Summary
Table 71. LG Chem Injectable Viscosupplementation for Joint Product Offerings
Table 72. LG Chem Injectable Viscosupplementation for Joint Sales (Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 73. LG Chem Key News & Latest Developments
Table 74. Freda Company Summary
Table 75. Freda Injectable Viscosupplementation for Joint Product Offerings
Table 76. Freda Injectable Viscosupplementation for Joint Sales (Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 77. Freda Key News & Latest Developments
Table 78. Haohai Biological Company Summary
Table 79. Haohai Biological Injectable Viscosupplementation for Joint Product Offerings
Table 80. Haohai Biological Injectable Viscosupplementation for Joint Sales (Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 81. Haohai Biological Key News & Latest Developments
Table 82. Shanghai Jingfeng Company Summary
Table 83. Shanghai Jingfeng Injectable Viscosupplementation for Joint Product Offerings
Table 84. Shanghai Jingfeng Injectable Viscosupplementation for Joint Sales (Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 85. Shanghai Jingfeng Key News & Latest Developments
Table 86. Injectable Viscosupplementation for Joint Production Capacity (Units) of Key Manufacturers in Global Market, 2021-2023 (Units)
Table 87. Global Injectable Viscosupplementation for Joint Capacity Market Share of Key Manufacturers, 2021-2023
Table 88. Global Injectable Viscosupplementation for Joint Production by Region, 2018-2023 (Units)
Table 89. Global Injectable Viscosupplementation for Joint Production by Region, 2024-2029 (Units)
Table 90. Injectable Viscosupplementation for Joint Market Opportunities & Trends in Global Market
Table 91. Injectable Viscosupplementation for Joint Market Drivers in Global Market
Table 92. Injectable Viscosupplementation for Joint Market Restraints in Global Market
Table 93. Injectable Viscosupplementation for Joint Raw Materials
Table 94. Injectable Viscosupplementation for Joint Raw Materials Suppliers in Global Market
Table 95. Typical Injectable Viscosupplementation for Joint Downstream
Table 96. Injectable Viscosupplementation for Joint Downstream Clients in Global Market
Table 97. Injectable Viscosupplementation for Joint Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Injectable Viscosupplementation for Joint Segment by Type in 2022
Figure 2. Injectable Viscosupplementation for Joint Segment by Application in 2022
Figure 3. Global Injectable Viscosupplementation for Joint Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Injectable Viscosupplementation for Joint Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Injectable Viscosupplementation for Joint Revenue, 2018-2029 (US$, Mn)
Figure 7. Injectable Viscosupplementation for Joint Sales in Global Market: 2018-2029 (Units)
Figure 8. The Top 3 and 5 Players Market Share by Injectable Viscosupplementation for Joint Revenue in 2022
Figure 9. By Type - Global Injectable Viscosupplementation for Joint Revenue, (US$, Mn), 2022 & 2029
Figure 10. By Type - Global Injectable Viscosupplementation for Joint Revenue Market Share, 2018-2029
Figure 11. By Type - Global Injectable Viscosupplementation for Joint Sales Market Share, 2018-2029
Figure 12. By Type - Global Injectable Viscosupplementation for Joint Price (US$/Unit), 2018-2029
Figure 13. By Application - Global Injectable Viscosupplementation for Joint Revenue, (US$, Mn), 2022 & 2029
Figure 14. By Application - Global Injectable Viscosupplementation for Joint Revenue Market Share, 2018-2029
Figure 15. By Application - Global Injectable Viscosupplementation for Joint Sales Market Share, 2018-2029
Figure 16. By Application - Global Injectable Viscosupplementation for Joint Price (US$/Unit), 2018-2029
Figure 17. By Region - Global Injectable Viscosupplementation for Joint Revenue, (US$, Mn), 2022 & 2029
Figure 18. By Region - Global Injectable Viscosupplementation for Joint Revenue Market Share, 2018 VS 2022 VS 2029
Figure 19. By Region - Global Injectable Viscosupplementation for Joint Revenue Market Share, 2018-2029
Figure 20. By Region - Global Injectable Viscosupplementation for Joint Sales Market Share, 2018-2029
Figure 21. By Country - North America Injectable Viscosupplementation for Joint Revenue Market Share, 2018-2029
Figure 22. By Country - North America Injectable Viscosupplementation for Joint Sales Market Share, 2018-2029
Figure 23. US Injectable Viscosupplementation for Joint Revenue, (US$, Mn), 2018-2029
Figure 24. Canada Injectable Viscosupplementation for Joint Revenue, (US$, Mn), 2018-2029
Figure 25. Mexico Injectable Viscosupplementation for Joint Revenue, (US$, Mn), 2018-2029
Figure 26. By Country - Europe Injectable Viscosupplementation for Joint Revenue Market Share, 2018-2029
Figure 27. By Country - Europe Injectable Viscosupplementation for Joint Sales Market Share, 2018-2029
Figure 28. Germany Injectable Viscosupplementation for Joint Revenue, (US$, Mn), 2018-2029
Figure 29. France Injectable Viscosupplementation for Joint Revenue, (US$, Mn), 2018-2029
Figure 30. U.K. Injectable Viscosupplementation for Joint Revenue, (US$, Mn), 2018-2029
Figure 31. Italy Injectable Viscosupplementation for Joint Revenue, (US$, Mn), 2018-2029
Figure 32. Russia Injectable Viscosupplementation for Joint Revenue, (US$, Mn), 2018-2029
Figure 33. Nordic Countries Injectable Viscosupplementation for Joint Revenue, (US$, Mn), 2018-2029
Figure 34. Benelux Injectable Viscosupplementation for Joint Revenue, (US$, Mn), 2018-2029
Figure 35. By Region - Asia Injectable Viscosupplementation for Joint Revenue Market Share, 2018-2029
Figure 36. By Region - Asia Injectable Viscosupplementation for Joint Sales Market Share, 2018-2029
Figure 37. China Injectable Viscosupplementation for Joint Revenue, (US$, Mn), 2018-2029
Figure 38. Japan Injectable Viscosupplementation for Joint Revenue, (US$, Mn), 2018-2029
Figure 39. South Korea Injectable Viscosupplementation for Joint Revenue, (US$, Mn), 2018-2029
Figure 40. Southeast Asia Injectable Viscosupplementation for Joint Revenue, (US$, Mn), 2018-2029
Figure 41. India Injectable Viscosupplementation for Joint Revenue, (US$, Mn), 2018-2029
Figure 42. By Country - South America Injectable Viscosupplementation for Joint Revenue Market Share, 2018-2029
Figure 43. By Country - South America Injectable Viscosupplementation for Joint Sales Market Share, 2018-2029
Figure 44. Brazil Injectable Viscosupplementation for Joint Revenue, (US$, Mn), 2018-2029
Figure 45. Argentina Injectable Viscosupplementation for Joint Revenue, (US$, Mn), 2018-2029
Figure 46. By Country - Middle East & Africa Injectable Viscosupplementation for Joint Revenue Market Share, 2018-2029
Figure 47. By Country - Middle East & Africa Injectable Viscosupplementation for Joint Sales Market Share, 2018-2029
Figure 48. Turkey Injectable Viscosupplementation for Joint Revenue, (US$, Mn), 2018-2029
Figure 49. Israel Injectable Viscosupplementation for Joint Revenue, (US$, Mn), 2018-2029
Figure 50. Saudi Arabia Injectable Viscosupplementation for Joint Revenue, (US$, Mn), 2018-2029
Figure 51. UAE Injectable Viscosupplementation for Joint Revenue, (US$, Mn), 2018-2029
Figure 52. Global Injectable Viscosupplementation for Joint Production Capacity (Units), 2018-2029
Figure 53. The Percentage of Production Injectable Viscosupplementation for Joint by Region, 2022 VS 2029
Figure 54. Injectable Viscosupplementation for Joint Industry Value Chain
Figure 55. Marketing Channels

※参考情報

関節用注射用ビスコサプリメントは、関節の健康を維持・改善するための治療法の一つです。特に、変形性関節症や関節の痛みを伴う状態に対して用いられ、関節内に直接注入される物質として知られています。これらのサプリメントは、関節の滑液の性質を模倣または改善することを目的としており、ここではその概念について詳しく説明いたします。

まず、ビスコサプリメントの基本的な定義について触れます。ビスコサプリメントは、主にヒアルロン酸や他の粘弾性物質で構成されており、関節液の粘度を向上させることによって、関節の滑らかさや動きの良さを保つ役割を果たします。ヒアルロン酸は、体内にも自然に存在する成分で、特に結合組織や皮膚、眼球などに広く分布しています。関節内においては、関節液の主要な成分として重要であり、潤滑作用や衝撃吸収作用があります。

次に、ビスコサプリメントの特徴を見ていきましょう。これらの製品は、一般的に生理食塩水に溶解された形で注射され、関節内に直接届けられます。その結果、関節内の潤滑が改善され、痛みが軽減されることが期待されます。特に変形性膝関節症や股関節症において使用されることが多いです。また、ビスコサプリメントは一回の注入で一定期間効果が持続するという特長もあり、その期間は製品によって異なりますが、数週間から数ヶ月に及ぶこともあります。

ビスコサプリメントの種類にはいくつかのバリエーションがあります。代表的なものとしては、単一成分のヒアルロン酸製剤、複数の成分を含む製剤（例えば、グルコサミンやコンドロイチンといった成分を含むもの）、そして新しい技術を用いた改良型の製剤などがあります。これらは、分子量、ゲルの状態、生産方法などによって差異があります。分子量が大きいものは、持続性が高いとされ、逆に小さいものは吸収が早く、即効性があるとされています。

関節用注射用ビスコサプリメントの主な用途は、関節痛の軽減や機能改善、そして、関節のさらなる障害の進行を遅らせることです。特に変形性関節症の患者にとって、日常生活における動作の自由度を増すことは、非常に重要な意味を持ちます。また、手術を避ける手段としても注目されています。手術が必要とされる前段階の治療法として、ビスコサプリメントは有効な選択肢となります。

さらに、関節用注射用ビスコサプリメントは、関連技術とも密接に関連しています。これには、画像診断技術（例：MRIや超音波）を用いることで、より正確に注射部位を特定し、適切な投与を行うことが挙げられます。また、バイオマテリアル技術の進展によって、より効果的な製剤の開発が進められています。例えば、ナノテクノロジーを応用した製品や、持続的に放出される設計が施されたものなどが研究されています。

最近では、関節用注射用ビスコサプリメントの再生医療への応用も注目されています。これには、幹細胞と組み合わせて使用する方法や、成長因子を追加して治療効果を高めるアプローチが含まれます。これにより、関節の修復を促進し、長期的な関節の機能を改善する可能性が期待されています。

最後に、関節用注射用ビスコサプリメントの安全性と有効性についても触れておく必要があります。臨床研究においては、一般的に副作用は少ないとされていますが、注射後の一時的な腫れや痛みが報告されることもあります。具体的な効果については、個人差があり、患者ごとの状態や後の治療経過により異なります。そのため、治療を行う医師との十分な相談と共に、適切な治療方針を選択することが重要です。

このように、関節用注射用ビスコサプリメントは、関節の健康を支えるための重要な選択肢であり、今後もさらなる技術革新と研究が期待される分野です。患者の生活の質を向上させるために、これらの治療法が有効に活用されていくことを願っています。

❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ 関節用注射用ビスコサプリメントの世界市場見通し2023年-2029年(Injectable Viscosupplementation for Joint Market, Global Outlook and Forecast 2023-2029)]についてメールでお問い合わせはこちらでお願いします。

GlobalResearch.jp

関節用注射用ビスコサプリメントの世界市場見通し2023年-2029年

グローバル市場調査/マーケットリサーチ会社：レポート販売と委託調査サービス提供 www.GlobalResearch.jp